Search Results - "Saarinen, U"

Refine Results
  1. 1

    Ovarian function after allogeneic hematopoietic stem cell transplantation in childhood and adolescence by Vatanen, A, Wilhelmsson, M, Borgström, B, Gustafsson, B, Taskinen, M, Saarinen-Pihkala, U M, Winiarski, J, Jahnukainen, K

    Published in European journal of endocrinology (01-02-2014)
    “…ObjectiveThe aim of the study was to evaluate long-term ovarian function after allogeneic hematopoietic stem cell transplantation (HSCT) in childhood and…”
    Get full text
    Journal Article
  2. 2

    Childhood cancer survival in Finland (1953–2010): A nation‐wide population‐based study by Madanat‐Harjuoja, L.M., Pokhrel, A., Kivivuori, S.M., Saarinen‐Pihkala, U.M.

    Published in International journal of cancer (01-11-2014)
    “…Population based survival studies are critical in monitoring changes in anticancer therapy, evaluating effectiveness of new treatments as well as identifying…”
    Get full text
    Journal Article
  3. 3

    Clinical and biological markers of premature aging after autologous SCT in childhood cancer by Vatanen, A, Hou, M, Huang, T, Söder, O, Jahnukainen, T, Kurimo, M, Ojala, T H, Sarkola, T, Turanlahti, M, Saarinen-Pihkala, U M, Jahnukainen, K

    Published in Bone marrow transplantation (Basingstoke) (01-04-2017)
    “…The aim of this study was to analyze the prevalence of frailty and physical health limitations among long-term survivors of high-risk neuroblastoma (HR NBL)…”
    Get full text
    Journal Article
  4. 4

    Higher angiopoietin-2 and VEGF levels predict shorter EFS and increased non-relapse mortality after pediatric hematopoietic SCT by Porkholm, M, Bono, P, Saarinen-Pihkala, U M, Kivivuori, S-M

    Published in Bone marrow transplantation (Basingstoke) (01-01-2013)
    “…The roles of angiogenesis and angiogenic factors after allogenic hematopoietic SCT (HSCT) and during acute GVHD (aGVHD) are not known. Studies on pediatric…”
    Get full text
    Journal Article
  5. 5

    Improving outcome through two decades in childhood ALL in the Nordic countries : the impact of high-dose methotrexate in the reduction of CNS irradiation by GUSTAFSSON, G, SCHMIEGELOW, K, FORESTIER, E, CLAUSEN, N, GLOMSTEIN, A, JONMUNDSSON, G, MELLANDER, L, MAKIPERNAA, A, NYGAARD, R, SAARINEN-PIHKALA, U. M

    Published in Leukemia (01-12-2000)
    “…In this population-based material from the five Nordic countries (Denmark, Finland, Iceland, Norway and Sweden), 2860 children below 15 years of age were…”
    Get full text
    Journal Article
  6. 6

    Adverse health events and late mortality after pediatric allogeneic hematopoietic SCT—two decades of longitudinal follow-up by Wilhelmsson, M, Vatanen, A, Borgström, B, Gustafsson, B, Taskinen, M, Saarinen-Pihkala, U M, Winiarski, J, Jahnukainen, K

    Published in Bone marrow transplantation (Basingstoke) (01-06-2015)
    “…Treatment-related late toxicities after pediatric allogeneic hematopoietic SCT (allo-HSCT) are increasingly important as long-term survival has become an…”
    Get full text
    Journal Article
  7. 7

    Breastfeeding as prophylaxis against atopic disease: prospective follow-up study until 17 years old by Saarinen, U M, Kajosaari, M

    Published in The Lancet (British edition) (21-10-1995)
    “…Atopic diseases constitute a common health problem. For infants at hereditary risk, prophylaxis of atopy has been sought in elimination diets and other…”
    Get more information
    Journal Article
  8. 8

    The Impact of Early Viral Infections and Graft‐Versus‐Host Disease on Immune Reconstitution Following Paediatric Stem Cell Transplantation by Olkinuora, H., von Willebrand, E., Kantele, J. M., Vainio, O., Talvensaari, K., Saarinen‐Pihkala, U., Siitonen, S., Vettenranta, K.

    Published in Scandinavian journal of immunology (01-06-2011)
    “…Viral infections and graft‐versus‐host disease (GVHD) render an impact on both the clinical and immunological recovery following allogeneic hematopoietic stem…”
    Get full text
    Journal Article
  9. 9

    Suboptimal long-term physical performance in children and young adults after pediatric allo-SCT by Hovi, L, Kurimo, M, Taskinen, M, Vettenranta, J, Vettenranta, K, Saarinen-Pihkala, U M

    Published in Bone marrow transplantation (Basingstoke) (01-04-2010)
    “…We present a set of tests for physical performance used for annual prospective follow-up after a pediatric transplant. Of the 103 eligible patients…”
    Get full text
    Journal Article
  10. 10

    Surgical treatment of neuroblastoma: twenty-three years of experience at a single institution by Koivusalo, A. I., Pakarinen, M. P., Rintala, R. J., Saarinen–Pihkala, U. M.

    Published in Surgery today (Tokyo, Japan) (01-03-2014)
    “…Purpose Neuroblastoma (NB) is treated with surgery, chemotherapy and radiotherapy. We assessed the effects of surgical resection on the outcome over a 23-year…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood by Taskinen, Menrvi, Saarinen-Pihkala, Ulla M, Hovi, Liisa, Lipsanen-Nyman, Mania

    Published in The Lancet (British edition) (16-09-2000)
    “…This follow-up study aimed to assess the frequency of late effects on glucose and lipid metabolism after bone-marrow transplantation in childhood. 23 long-term…”
    Get full text
    Journal Article
  14. 14

    Long-term adverse effects on dentition in children with poor-risk neuroblastoma treated with high-dose chemotherapy and autologous stem cell transplantation with or without total body irradiation by HÖLTTÄ, P, ALALUUSUA, S, SAARINEN-PIHKALA, U. M, WOLF, J, NYSTRÖM, M, HOVI, L

    “…Chemo- and radiotherapy may have injurious effects on developing teeth. In this long-term follow-up study among poor-risk neuroblastoma (NBL) survivors our…”
    Get full text
    Journal Article
  15. 15

    Dendritic cell subsets in childhood and in children with cancer: relation to age and disease prognosis by VAKKILA, J., THOMSON, A. W., VETTENRANTA, K., SARIOLA, H., SAARINEN‐PIHKALA, U. M.

    Published in Clinical and experimental immunology (01-03-2004)
    “…SUMMARY Dendritic cells (DC) are a heterogeneous group of uniquely well‐equipped bone marrow‐derived antigen‐presenting cells. They circulate in blood as…”
    Get full text
    Journal Article
  16. 16

    Circulating dendritic cell subset levels after allogeneic stem cell transplantation in children correlate with time post transplant and severity of acute graft-versus-host disease by VAKKILA, J, THOMSON, A. W, HOVI, L, VETTENRANTA, K, SAARINEN-PIHKALA, U. M

    Published in Bone marrow transplantation (Basingstoke) (01-03-2005)
    “…We examined the recovery of circulating monocytoid (Lin- CD11+ HLA-DR+) and plasmacytoid (Lin- CD123+ HLA-DR+) precursor (pre) dendritic cell (DC) subsets…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Terminal care of the child with cancer at home by Sirkiä, K., Saarinen, UM, Ahlgren, B., Hovi, L.

    Published in Acta Paediatrica (01-10-1997)
    “…One hundred paediatric patients with either leukaemia (36%), solid tumours (34%) or brain tumours (30%), treated at the Children's Hospital, University of…”
    Get full text
    Journal Article
  19. 19

    Hematopoietic stem cell transplantation in infantile neuronal ceroid lipofuscinosis by LONNQVIST, T, VANHANEN, S. L, VETTENRANTA, K, AUTTI, T, RAPOLA, J, SANTAVUORI, P, SAARINEN-PIHKALA, U. M

    Published in Neurology (23-10-2001)
    “…To study the effect of allogeneic hematopoietic stem cell transplantation (SCT) on the clinical course of infantile neuronal ceroid lipofuscinosis (INCL), a…”
    Get full text
    Journal Article
  20. 20

    Skeletal outcome in long-term survivors of childhood high-risk neuroblastoma treated with high-dose therapy and autologous stem cell rescue by Utriainen, P, Vatanen, A, Toiviainen-Salo, S, Saarinen-Pihkala, U, Mäkitie, O, Jahnukainen, K

    Published in Bone marrow transplantation (Basingstoke) (01-05-2017)
    “…High-dose therapy and hematopoietic stem cell transplantation (HSCT) have been shown to improve survival rates in high-risk neuroblastoma (HR-NBL), but may…”
    Get full text
    Journal Article